1350 results for Leukemia
Refine Your Search
Leveraging the ubiquitin proteasome system for targeted therapy in Acute Myeloid Leukemia
This research proposal will investigate the role of protein degradation in acute myeloid leukemia (AML). Specifically, we will assess the function of…
Affinity-Tuned T-Cell Engagers for Dual Targeting of B-Myeloid Mixed Phenotype Acute Leukemia
Our objective is to develop a highly specific engaging therapy to treat a subtype of leukemia that currently lacks effective treatment. We also aim t…
The Leukemia & Lymphoma Society Receives Grant Award from Disabled Veterans National Foundation
Rye Brook, NY- July , – The Leukemia & Lymphoma Society (LLS) is honored to announce it has received a grant from the Disabled Veterans National Foun…
News Release
The Leukemia & Lymphoma Society Names Lore Gruenbaum, Ph.D., New Chief Scientific Officer
Lore Gruenbaum, Ph.D., will oversee the planning and execution of the strategy for all LLS’s research programs Dr. Gruenbaum succeeds Lee Greenberger,…
Healthcare Professional
Immunotherapy Greatly Improves Survival for Infants with an Aggressive Form of Leukemia
These results mark a big step forward in the treatment of infants with this form of Acute Lymphoblastic Leukemia (ALL).
News Release
A phase 1b/2 study targeting apoptotic and signaling pathways in T-acute lymphoblastic leukemia
lymphoblastic leukemia () is an aggressive leukemia with limited treatment options after chemotherapy. Our preclinical work in animal models of demo…
THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) INVESTS $3.8 MILLION TO ADVANCE HEALTH EQUITY
LLS’s Equity in Access Research Program Awards Five New Grants to Researchers Across the U.S. Aiming to Break Down Barriers to Care for Blood Cancer P…
News Release
The Leukemia & Lymphoma Society Applauds Bipartisan Agreement to Stop Surprise Medical Bills
Patients are now one step closer to breathing a sigh of relief. For too long, they’ve faced the anxiety of knowing that any visit to a healthcare prov…
News Release
FDA Expands Use of Targeted Therapy for Most Common Leukemia in Adults
The FDA this week approved pirtobrutinib (Jaypirca®) for the treatment of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in ad…
Blood Cancer
News Release
Treatment
_dam_file_94341.jpg?crop=true&keep=n&w=400&h=400)
Mateo
On June , , at years old, Mateo was diagnosed with acute lymphoblastic leukemia (ALL). Our world was completely upside down since that night. Our hea…
NCI-Genetic Epidemiology Branch - Familial CLL
To study families with multiple cases of chronic lymphocytic leukemia (CLL). The National Cancer Institute (NCI) of the National Institutes of H…
Stefan
Not that long ago, leukemia was an invariably fatal disease. These cancers presented with such ferocity and aggression that, in many cases, patient de…
Suggested Reading - When Blood Breaks Down
In When Blood Breaks Down, Dr. Mikkael Sekeres, a leading cancer specialist, takes readers on a journey that patient and doctor travel together. Seke…
Judy
Meet Judy, a leukemia survivor, and teacher. Given a death sentence of chronic myeloid leukemia (CML), Oregon native Judy prepared to have her ashes s…
Lawrence
I am currently getting treatment for acute myeloid leukemia (AML). This is my fifth cancer diagnosis.I have overcome prostate cancer, lymphoma (NHL),…
Stories
Bishoy
Leukemia Survivor Travels From Egypt to Receive Treatment At just three years old, Bishoy’s parents uprooted him and his family from Egypt to Ameri…
Stars Will Twinkle, The Sun Will Shine
Available in English and SpanishWritten and illustrated to explain the cancer journey to young children. Follow Olivia and her family in this -book se…
Chuck
Meet Chuck a leukemia survivor.He is the Indianapolis Colts Head Coach, "My condition was leukemia. But my position was, I'm walking out of here. For …
Monica
Our daughter, Monica, is a busy mother of three sweet girls, age months, years and years. After a long winter filled with the girls’ colds, infecti…
Brian
Our family has once again joined the fight to beat leukemia and lymphoma together with the support of The Leukemia & Lymphoma Society (LLS). I am a ca…
Andreas, Ph.D., MSc, FAA
A Pioneering Researcher Developing Targeted Therapies for Leukemia, Lymphoma and MyelomaA cancer researcher trained in cell biology, immunology and mo…
Tom
Hello Friends — this is my leukemia journey, For those of you who don’t know me, my entire -year teaching career was spent with - year olds. I’ve alwa…
Imatinib mesylate
Generic name Imatinib mesylate Pronunciation Brand name(s), other common name(s) Gleevec® Drug type…
Memory-like natural killer cells and venetoclax to eradicate measurable residual disease in AML
This proposal is to conduct a phase I (early phase) clinical trial to test whether the combination of the approved targeted therapy venetoclax with N…
Janet
I support LLS because leukemia and lymphoma has impacted my family. On Mother’s Day, in , my cousin's - daughter, Sydney, was diagnosed with acute mye…